SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-263977
Filing Date
2019-10-08
Accepted
2019-10-07 21:33:35
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B5 d813809d424b5.htm 424B5 445166
2 GRAPHIC g813809g01m54.jpg GRAPHIC 52752
3 GRAPHIC g813809g11s45.jpg GRAPHIC 145684
4 GRAPHIC g813809g12j10.jpg GRAPHIC 61721
5 GRAPHIC g813809g50a99.jpg GRAPHIC 54995
6 GRAPHIC g813809g51n10.jpg GRAPHIC 51342
7 GRAPHIC g813809g84k55.jpg GRAPHIC 178733
8 GRAPHIC g813809g85u26.jpg GRAPHIC 85755
9 GRAPHIC g813809g97t53.jpg GRAPHIC 52571
  Complete submission text file 0001193125-19-263977.txt   1388421
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-225391 | Film No.: 191141749
SIC: 2834 Pharmaceutical Preparations